Search Results for: CRISPR
Funding RNA Editing
Korro Bio Raises $116 Million for RNA Editing Program
2022-01-06
Ranking & Reports
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
Innovation CRISPR
Harnessing the potential of CRISPR-Cas9 for Gut Microbiome Gene Editing
2021-11-29
Trials & Approvals Acute Myeloid Leukemia
FDA Places Clinical Hold on Kura Oncology’s Acute Myeloid Leukemia Therapeutic
2021-11-25
Special Virus
Breakthrough Cryo-EM Study Reveals How Viral RNA Hijacks Host Machinery
2021-11-24
Trials & Approvals Cancer
FDA Approves Aadi Bioscience’s First Product to Treat Rare Cancer
2021-11-23
Licensing mRNA Technology
Sanofi Bets on Baidu’s Algorithm to Develop mRNA-Based Therapeutics
2021-11-23
Special CRISPR
Study Advocates Cautious Application of CRISPR in Designing Therapeutics
2021-11-22
Funding Gene Editing
Chroma Medicine Debuts with High Hopes for “Game-Changing” Epigenetic Genome Editors
2021-11-17
Trials & Approvals Type 1 Diabetes
Canadian Regulators Give Go-Ahead for Diabetes Trial Using CRISPR, ViaCyte’s Gene-Edited Stem Cell-Derived Therapy
2021-11-16
Licensing Gene Writing
Tessera Therapeutics Partners with Cystic Fibrosis Foundation to Treat Life-Threatening Disease with Gene Writers
2021-11-05
Deals Gene Editing
Moderna Enters Gene Editing Market with Metagenomi Collaboration
2021-11-03
Licensing Respiratory Disease
AstraZeneca Trims Pipeline By Selling Two Respiratory Drugs to Covis Pharma
2021-11-02
China IPO
Shanghai Startup Lands $325 Million Nasdaq IPO to Advance Phase 3 Assets
2021-11-02
Asia-Pacific Orphan Drug Designation
GC Pharma’s Enzyme Replacement Therapy Wins Orphan Drug Designation from EMA
2021-11-02
1 … 3 4 5 6 7 … 16
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top